Nevirapin-Mepha 400 mg, Retardtabletten

7680663180023 CH-66318 Tabletten

Associated product:

NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
Nevirapin-Mepha 400 mg, Retardtabletten
Nevirapin-Mepha 400 mg, Retardtabletten
Nevirapin-Mepha 400 mg, Retardtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/03/2023
Patient information leaflet
Français
31/03/2023
Patient information leaflet
Italien
31/03/2023
Summary of Product Characteristics
Allemand
31/03/2023
Summary of Product Characteristics
Français
31/03/2023
Summary of Product Characteristics
Italien
31/03/2023

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66318
Drug name
Nevirapin-Mepha, Retardtabletten
Galenic form
RETT
ATC Code
J05AG01
Authorization status
Z
Dispensing category
A
First authorization
23/11/2016
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
Description (DE)
NEVIRAPIN Mepha Ret Tabl 400 mg Blist 30 Stk
Market launch
23/11/2016
Narcotic (BTM)
No

Original drug

Viramune, Retardtabletten
GTIN: 7680620770014
CHF 211.90
View original

Other package sizes (1)

None
30 TABL
GTIN: None
Not in V1